Back

Role of CMR for personalised risk stratification in STEMI.

2 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Magnetic Resonance in acute coronary syndromes: luxury or do we need it? Late Gadolinium Enhancement EACVI Premium Access EuroCMR 2019

About the speaker

Photo
Doctor Andrew Arai

National Institutes of Health (NIH), Bethesda (United States of America)

4 More presentations in this session

Presentation thumbnail
CMR to manage PCI strategies in acute myocardial infarction.
Professor H. Thiele (Leipzig, DE)
Slides Video
Presentation thumbnail
Pursuing the correct diagnosis in myocardial infarction non-obstructive coronary artery disease (MINOCA) by CMR.
Professor I. Eitel (Luebeck, DE)
Slides Video
Presentation thumbnail
Is there any possible role of CMR in N-STEMI?
Professor H. Sakuma (Tsu, JP)
Slides Video
Presentation thumbnail
The role of imaging in women with ischaemic heart disease: improving management and outcomes.
Doctor W. Chan (Hong Kong, HK)
Slides Video

Access the full session

Session thumbnail
Cardiovascular Magnetic Resonance in acute coronary syndromes: luxury or do we need it?

The Event

Event poster

EuroCMR 2019

2 May - 4 May 2019
You may be interested in
thumbnail
Congress Presentation
CMR in acute coronary syndrome: optional or essential? - discussion
thumbnail
Congress Presentation
Late gadolinium enhancement and viability
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources